New pill shows promise for Hard-to-Treat leukemias
Disease control
Completed
This early-phase trial tested an experimental pill called LP-108, given alone or with another drug (azacitidine), in 32 adults whose myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia had returned or stopped responding to prior treatments. The m…
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 08, 2026 13:03 UTC